Velocity Clinical Research

DECEMBER 6, 2023

In addition to being one of Poland’s top recruiting sites in cardiology trials, ClinMedica also recruits patients across a broad range of therapeutic areas involving ambulatory medicine. Not enough people in smaller cities have the opportunity or access to clinical research, which could be their only lifeline to innovative treatments.

Clinical Research 52

Clinical Research Research Clinical Trials Clinical Trials 52

Velocity Clinical Research

JANUARY 3, 2024

The acquisition of KO-MED is Velocity’s first foray into Oncology research, which accounts for roughly 40-50% of clinical trials globally. KO-MED has been the leading multi-site network in Poland since 2020, having enrolled over 9,000 patients into clinical research.

Clinical Trials 52

Clinical Trials Clinical Trials Clinical Research Trials 52

The Pharma Data

NOVEMBER 4, 2020

If your doctor decided that urgent treatment with ULTOMIRIS is needed, you should receive meningococcal vaccination as soon as possible. Your doctor will decide if you need additional vaccination. Your doctor will give you a Patient Safety Card about the risk of meningococcal infection.

Doctors 52

Doctors Doctor Vaccination Vaccine 52

The Pharma Data

JULY 8, 2021

The EMPEROR heart failure studies are part of our EMPOWER clinical trial program exploring the effect of Jardiance across a spectrum of cardio-renal-metabolic diseases, aiming to significantly improve outcomes in these highly prevalent conditions that impact many people’s lives.” In the U.S.,

Trials 52

Trials Doctors Doctor Medicine 52

The Pharma Data

NOVEMBER 4, 2020

District Court ruling in favor of two generic companies in connection with their abbreviated new drug applications, or ANDAs, related to VASCEPA capsules in its initial triglyceride lowering indication. . Reaffirmed strategy to continue increasing U.S. promotion of VASCEPA : As reported, the U.S. commercial team. “In

Sales 40

Sales Production Cardiology Marketing 40

Delveinsight

AUGUST 3, 2021

The Late-Breaking Trial Data at TVT Prove Sustained Safety and Performance of WATCHMAN FLX Left Atrial Appendage Closure Device. According to analyst views, interventional cardiology sales grew at around 7% in the first quarter of 2021 versus 2020 with structural heart franchise WATCHMAN, ACURATE neo2, and SENTINEL.

FDA Approval 98

FDA Approval Marketing Cardiology Production 98

The Pharma Data

NOVEMBER 16, 2020

The “polypill” containing three generic blood pressure medications and a statin dramatically reduced the risk of heart-related illness in people with no prior history of heart problems, according to clinical trial results. Salim Yusuf, a professor of medicine at McMaster University in Canada.

Doctors 52

Doctors Doctor Cardiology Pharma Companies 52